Letavernier, Emmanuel <br/><br/>
Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.  [electronic resource] 

 -  Circulation research  Mar 2008 
 - 720-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4571 
<br/><br/><label>Standard No.: </label>10.1161/CIRCRESAHA.107.160077  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin II--administration & dosage<br/>Animals<br/>Aorta--enzymology<br/>Blood Pressure<br/>Calcium-Binding Proteins--genetics<br/>Calpain--antagonists & inhibitors<br/>Cysteine Proteinase Inhibitors--genetics<br/>Disease Models, Animal<br/>Fibrosis<br/>Genetic Therapy--methods<br/>Hypertension--chemically induced<br/>Hypertrophy<br/>Hypertrophy, Left Ventricular--etiology<br/>Inflammation--etiology<br/>Infusion Pumps, Implantable<br/>Mice<br/>Mice, Transgenic<br/>Muscle, Smooth, Vascular--metabolism<br/>Myocardium--enzymology<br/>NF-kappa B--metabolism<br/>NFATC Transcription Factors--metabolism<br/>Renal Artery--enzymology<br/>Time Factors<br/>Ventricular Remodeling